Peak Bio, Inc. filed its 10-K on Jun 29, 2023 for the period ending Dec 31, 2022. In this report its auditor, Mayer Hoffman McCann P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0096 USD | +11.63% |
|
+11.63% | -94.88% |
06-25 | Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
05-28 | Peak Bio, Inc. announced that it has received $1.3245 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-94.88% | 222K | |
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+36.36% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Peak Bio, Inc. Auditor Raises 'Going Concern' Doubt